Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04766216 · ClinicalTrials.gov registry record · NA
Warfarin Patient Self-management Implementation in the US Healthcare System
A NA study of Atrial Fibrillation and Venous Thromboembolism, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 4
- Study locations
NCT04766216 is a NA study of Atrial Fibrillation and Venous Thromboembolism that is actively recruiting participants, run by University of Utah. The registered enrollment target is 150 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT04766216, a NA study of Atrial Fibrillation and Venous Thromboembolism, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 4
- Study locations
Study Summary
In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.
Conditions Studied
Interventions
- OTHER Patient self-management
- OTHER Usual care provided by anticoagulation providers
Study Locations (4)
California
- VA Loma Linda Healthcare System - Loma Linda
Massachusetts
- Brigham and Women's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Utah
- University of Utah Thrombosis Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04766216
The ClinicalTrials.gov registry entry for NCT04766216 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Patient self-management is the first listed.
NCT04766216 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT04766216 about?
NCT04766216 is a clinical study titled "Warfarin Patient Self-management Implementation in the US Healthcare System". In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfar...
What is the current status of trial NCT04766216?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-03-15. Estimated completion is 2025-04-30.
What conditions does trial NCT04766216 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases.
What interventions are being tested in trial NCT04766216?
The interventions under investigation include: Patient self-management (OTHER), Usual care provided by anticoagulation providers (OTHER).
Who is sponsoring clinical trial NCT04766216?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04766216 being conducted?
This trial has 4 study locations across California, Massachusetts, Michigan, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.